Epitomee Medical Ltd (TLV: EPIT)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
889.90
-29.30 (-3.19%)
Jan 21, 2025, 5:24 PM IDT
133.75%
Market Cap 265.30M
Revenue (ttm) 37.17M
Net Income (ttm) 9.90M
Shares Out 29.81M
EPS (ttm) 0.32
PE Ratio 27.93
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 174,094
Average Volume 52,594
Open 916.70
Previous Close 919.20
Day's Range 850.00 - 930.00
52-Week Range 249.40 - 1,570.00
Beta 0.87
RSI 43.72
Earnings Date Mar 18, 2025

About Epitomee Medical

Epitomee Medical Ltd, a biomedical company, develops and commercializes ingestible therapeutic devices worldwide. Its capsule is used for weight management, waist circumference reduction, and cardiovascular risk factors reduction. Epitomee Medical Ltd has a strategic partnership with Nestlé Health Science S.A. for the development and commercialization of the weight loss capsule. The company was incorporated in 2005 and is based in Caesarea, Israel. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2005
Employees 42
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol EPIT
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.